Overview
Curai Health offers AI-assisted telemedicine for non-emergency care through a digital platform that combines AI chatbots with human doctors for virtual consultations. Patients subscribe monthly or annually to access medical advice, diagnoses, and treatment plans without in-person visits, making care easier and more affordable. The service can partner with employers and insurers to broaden reach as part of health benefits. Curai aims to improve access to medical care and reduce costs by using AI to streamline virtual consultations.
Work here?Claim your company
Simplify's take
What believers are saying
- Walmart launched Curai weight-management services on April 16, 2026.
- WorkWhile expanded free Curai virtual care to all workers on June 11, 2026.
- Manchester's November 9, 2026 JV shortlisted Curai for clinical trials.
What critics are saying
- Curai's 91% diagnostic agreement still missed three urgent cases across 2,300.
- FDA rejection would block autonomous deployment and collapse Curai's valuation case.
- Walmart, WorkWhile, and Medicare can switch to Teladoc, Wheel, or Amazon Clinic quickly.
What makes Curai unique
- Curai combines chat-based primary care with clinician oversight and AI triage.
- Medicare selected Curai in 2026; FDA application targets autonomous AI primary care doctors.
- Walmart and WorkWhile distribute Curai through employer and retail benefit channels.
Help us improve and share your feedback! Did you find this helpful?
Funding
Notable Investors:
Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Industry standards
Ind Avg. $35M
$4M
$27.5M
$30M
$45M
$65M
$100M